| TP53 mutations and outcomes in breast cancer: reading beyond the headlines A Shahbandi, HD Nguyen, JG Jackson Trends in cancer 6 (2), 98-110, 2020 | 137 | 2020 |
| Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival CA Tonnessen-Murray, WD Frey, SG Rao, A Shahbandi, NA Ungerleider, ... Journal of Cell Biology 218 (11), 3827-3844, 2019 | 108 | 2019 |
| Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment NA Ungerleider, SG Rao, A Shahbandi, D Yee, T Niu, WD Frey, ... Breast Cancer Research 20, 1-8, 2018 | 96 | 2018 |
| BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer A Shahbandi, SG Rao, AY Anderson, WD Frey, JO Olayiwola, ... Cell Death & Differentiation 27 (11), 3097-3116, 2020 | 88 | 2020 |
| Medical students’ ability to diagnose common dermatologic conditions in skin of color A Fenton, E Elliott, A Shahbandi, E Ezenwa, C Morris, J McLawhorn, ... Journal of the American Academy of Dermatology 83 (3), 957-958, 2020 | 72 | 2020 |
| Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80 A Shahbandi, FY Chiu, NA Ungerleider, R Kvadas, Z Mheidly, MJS Sun, ... Nature cancer 3 (12), 1513-1533, 2022 | 30 | 2022 |
| Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity A Shahbandi, JG Jackson NPJ Precision Oncology 3 (1), 1, 2019 | 15 | 2019 |
| Receptor regulation in taste: can diet influence how we perceive foods? AA Shahbandi, E Choo, R Dando J 1 (1), 106-115, 2018 | 13 | 2018 |
| TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines. Trends Cancer, 6, 98-110 A Shahbandi, HD Nguyen, JG Jackson | 6 | 2020 |
| Could senescence phenotypes strike the balance to promote tumor dormancy? FY Chiu, RM Kvadas, Z Mheidly, A Shahbandi, JG Jackson Cancer and Metastasis Reviews 42 (1), 143-160, 2023 | 3 | 2023 |
| Long-term exposure to taste stimuli up-regulates PLC beta 2 expression in mouse taste buds A Shahbandi, E Choo, R Dando CHEMICAL SENSES 41 (7), E80-E80, 2016 | 3 | 2016 |
| Chemotherapy-induced senescence activates robust, parallel programs of immune checkpoint expression that can be targeted with immunotherapy A Shahbandi, FY Chiu, NA Ungerleider, AY Anderson, HL Machado, ... Cancer Research 82 (12_Supplement), 1297-1297, 2022 | | 2022 |
| Analysis of race and gender disparities in incidence-based mortality in patients diagnosed with thyroid cancer from 2000 to 2014. J Cintron-Garcia, LP Pappoppula, A Shahbandi, T Komiya, A Guddati Journal of Clinical Oncology 38 (15_suppl), e18570-e18570, 2020 | | 2020 |
| MECHANISMS OF IMMUNE EVASION IN CHEMOTHERAPY INDUCED SENESCENT BREAST CANCER CELLS A Shahbandi, JG Jackson JOURNAL OF INVESTIGATIVE MEDICINE 68 (2), 622-623, 2020 | | 2020 |
| Nation-wide trends in mortality of patients with ocular and orbit melanoma: 2000 to 2014. W Forehand, S Gopishetty, A Shahbandi, AK Guddati Journal of Clinical Oncology 37 (15_suppl), e21061-e21061, 2019 | | 2019 |
| cfDNA TP53 mutations with treatment history and disease progression in metastatic CRPC. L Chapman, E Ledet, MM Moses, A Shahbandi, P Steinwald, ... Journal of Clinical Oncology 36 (6_suppl), 263-263, 2018 | | 2018 |
| Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer. P Steinwald, E Ledet, BR Christensen, MM Moses, L Chapman, ... Journal of Clinical Oncology 36 (6_suppl), 255-255, 2018 | | 2018 |
| cfDNA analysis of mCRPC patients expressing mutations in Wnt signaling. A Shahbandi, E Ledet, BR Christensen, MM Moses, P Steinwald, ... Journal of Clinical Oncology 36 (6_suppl), 256-256, 2018 | | 2018 |
| Cosegregation of cfDNA AR amplifications and mutations in relation to BRAF and MYC in CRPC. BR Christensen, E Ledet, MM Moses, L Chapman, P Steinwald, ... Journal of Clinical Oncology 36 (6_suppl), 261-261, 2018 | | 2018 |
| Connective Tissue Growth Factor Induces Anti-Apoptotic Factors in Chronic Myeloid Leukemia Stem Cells PC Chang, JM Low-Marchelli, A Shahbandi, DJ Goff, C Jamieson Blood, The Journal of the American Society of Hematology 124 (21), 1785-1785, 2014 | | 2014 |
